Dennis Roop
Concepts (838)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epidermis | 84 | 2024 | 157 | 8.890 |
Why?
| | Keratins | 113 | 2016 | 173 | 6.970 |
Why?
| | Keratinocytes | 56 | 2024 | 249 | 4.350 |
Why?
| | Skin Neoplasms | 57 | 2024 | 855 | 3.980 |
Why?
| | Membrane Proteins | 39 | 2022 | 1164 | 3.720 |
Why?
| | Skin | 53 | 2024 | 752 | 3.350 |
Why?
| | Trans-Activators | 26 | 2013 | 398 | 2.920 |
Why?
| | Papilloma | 31 | 2011 | 52 | 2.130 |
Why?
| | Cell Transformation, Neoplastic | 25 | 2016 | 327 | 2.110 |
Why?
| | Phosphoproteins | 17 | 2013 | 338 | 2.110 |
Why?
| | Cell Differentiation | 74 | 2024 | 1991 | 2.070 |
Why?
| | Hyperkeratosis, Epidermolytic | 17 | 2008 | 21 | 2.030 |
Why?
| | Mice, Transgenic | 66 | 2017 | 2167 | 1.960 |
Why?
| | NF-E2-Related Factor 2 | 7 | 2022 | 93 | 1.930 |
Why?
| | Stem Cells | 19 | 2017 | 594 | 1.900 |
Why?
| | Mice | 189 | 2024 | 17787 | 1.790 |
Why?
| | Genes, ras | 25 | 2012 | 97 | 1.570 |
Why?
| | Animals | 232 | 2024 | 36940 | 1.510 |
Why?
| | Hair Follicle | 14 | 2020 | 46 | 1.420 |
Why?
| | Genetic Therapy | 12 | 2014 | 297 | 1.280 |
Why?
| | Vitiligo | 8 | 2024 | 42 | 1.270 |
Why?
| | Mutation | 37 | 2024 | 3958 | 1.140 |
Why?
| | Melanocytes | 8 | 2024 | 65 | 1.130 |
Why?
| | Point Mutation | 13 | 2009 | 235 | 1.120 |
Why?
| | Skin Diseases | 8 | 2014 | 149 | 1.060 |
Why?
| | Induced Pluripotent Stem Cells | 6 | 2024 | 248 | 1.050 |
Why?
| | Carcinoma, Squamous Cell | 20 | 2016 | 683 | 1.020 |
Why?
| | Transforming Growth Factor alpha | 10 | 2000 | 57 | 0.950 |
Why?
| | Collagen Type VII | 2 | 2024 | 28 | 0.940 |
Why?
| | Cell Division | 20 | 2016 | 794 | 0.930 |
Why?
| | Ichthyosis | 7 | 2016 | 13 | 0.930 |
Why?
| | Mice, Knockout | 35 | 2018 | 3015 | 0.920 |
Why?
| | Disease Models, Animal | 31 | 2020 | 4295 | 0.920 |
Why?
| | Epidermolysis Bullosa Dystrophica | 2 | 2024 | 41 | 0.920 |
Why?
| | Gene Expression Regulation | 31 | 2016 | 2607 | 0.870 |
Why?
| | Ectodermal Dysplasia | 5 | 2009 | 19 | 0.860 |
Why?
| | Phenotype | 28 | 2021 | 3196 | 0.860 |
Why?
| | Cornified Envelope Proline-Rich Proteins | 7 | 2018 | 9 | 0.850 |
Why?
| | Morphogenesis | 7 | 2010 | 166 | 0.850 |
Why?
| | Base Sequence | 49 | 2016 | 2181 | 0.830 |
Why?
| | Melanoma | 10 | 2020 | 760 | 0.830 |
Why?
| | Gene Expression Regulation, Developmental | 14 | 2015 | 860 | 0.830 |
Why?
| | Ultraviolet Rays | 9 | 2024 | 396 | 0.820 |
Why?
| | DNA-Binding Proteins | 15 | 2015 | 1502 | 0.820 |
Why?
| | Genes, fos | 10 | 2000 | 36 | 0.810 |
Why?
| | Neoplasms, Experimental | 4 | 2019 | 176 | 0.790 |
Why?
| | Transgenes | 13 | 2016 | 180 | 0.780 |
Why?
| | Genes, p53 | 10 | 2012 | 72 | 0.780 |
Why?
| | Tetradecanoylphorbol Acetate | 21 | 2010 | 150 | 0.770 |
Why?
| | Proto-Oncogene Proteins c-myc | 6 | 2010 | 139 | 0.760 |
Why?
| | Tumor Suppressor Proteins | 8 | 2009 | 327 | 0.760 |
Why?
| | Tumor Suppressor Protein p53 | 6 | 2011 | 528 | 0.730 |
Why?
| | Gene Expression Regulation, Neoplastic | 18 | 2015 | 1396 | 0.730 |
Why?
| | Skin Pigmentation | 4 | 2024 | 49 | 0.730 |
Why?
| | Cells, Cultured | 39 | 2024 | 4193 | 0.730 |
Why?
| | Intermediate Filament Proteins | 22 | 2012 | 57 | 0.730 |
Why?
| | Jews | 1 | 2021 | 23 | 0.720 |
Why?
| | Skin Physiological Phenomena | 7 | 2008 | 25 | 0.710 |
Why?
| | Neoplastic Stem Cells | 7 | 2016 | 399 | 0.660 |
Why?
| | Cell Lineage | 5 | 2010 | 350 | 0.660 |
Why?
| | Ichthyosis, Lamellar | 2 | 2016 | 9 | 0.640 |
Why?
| | Intravital Microscopy | 1 | 2019 | 25 | 0.630 |
Why?
| | Cytoskeletal Proteins | 9 | 2012 | 158 | 0.630 |
Why?
| | Transcription Factors | 16 | 2015 | 1719 | 0.620 |
Why?
| | Molecular Sequence Data | 34 | 2012 | 2900 | 0.610 |
Why?
| | Genes, myc | 4 | 2011 | 48 | 0.610 |
Why?
| | Signal Transduction | 22 | 2020 | 5079 | 0.570 |
Why?
| | Pluripotent Stem Cells | 2 | 2010 | 80 | 0.570 |
Why?
| | Hair | 6 | 2012 | 84 | 0.560 |
Why?
| | Hedgehog Proteins | 7 | 2017 | 195 | 0.560 |
Why?
| | Genes | 15 | 2008 | 230 | 0.560 |
Why?
| | Immunity, Cellular | 1 | 2019 | 268 | 0.550 |
Why?
| | Skin Diseases, Genetic | 6 | 2020 | 12 | 0.550 |
Why?
| | Keratin-6 | 5 | 2016 | 6 | 0.530 |
Why?
| | Mice, Mutant Strains | 14 | 2016 | 298 | 0.530 |
Why?
| | Promoter Regions, Genetic | 17 | 2016 | 1250 | 0.510 |
Why?
| | Multipotent Stem Cells | 3 | 2010 | 20 | 0.500 |
Why?
| | Protein Isoforms | 8 | 2008 | 404 | 0.500 |
Why?
| | Amino Acid Sequence | 30 | 2012 | 2139 | 0.490 |
Why?
| | Humans | 132 | 2024 | 137585 | 0.490 |
Why?
| | Ultraviolet Therapy | 4 | 2024 | 16 | 0.480 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2016 | 137 | 0.480 |
Why?
| | Keratoderma, Palmoplantar | 3 | 2014 | 5 | 0.480 |
Why?
| | Head and Neck Neoplasms | 5 | 2016 | 606 | 0.480 |
Why?
| | Cell Proliferation | 14 | 2024 | 2475 | 0.470 |
Why?
| | Transforming Growth Factor beta | 8 | 2009 | 480 | 0.470 |
Why?
| | Pachyonychia Congenita | 3 | 2014 | 4 | 0.460 |
Why?
| | Viral Proteins | 4 | 2002 | 342 | 0.460 |
Why?
| | Genetic Vectors | 7 | 2013 | 319 | 0.460 |
Why?
| | Tretinoin | 11 | 2014 | 123 | 0.450 |
Why?
| | Gene Deletion | 8 | 2012 | 391 | 0.440 |
Why?
| | Keratosis | 7 | 2000 | 16 | 0.440 |
Why?
| | Animals, Newborn | 23 | 2007 | 844 | 0.440 |
Why?
| | Epithelium | 14 | 2004 | 313 | 0.440 |
Why?
| | Cell Culture Techniques | 3 | 2014 | 363 | 0.440 |
Why?
| | Cadherins | 3 | 2016 | 206 | 0.430 |
Why?
| | DNA | 24 | 2018 | 1459 | 0.430 |
Why?
| | Cell Cycle | 3 | 2012 | 601 | 0.430 |
Why?
| | Mice, Inbred ICR | 10 | 2011 | 119 | 0.420 |
Why?
| | Genes, Dominant | 6 | 2016 | 96 | 0.420 |
Why?
| | Amniotic Fluid | 2 | 2012 | 96 | 0.410 |
Why?
| | Mosaicism | 5 | 2014 | 73 | 0.410 |
Why?
| | Nails, Malformed | 2 | 2005 | 5 | 0.400 |
Why?
| | Up-Regulation | 8 | 2020 | 843 | 0.400 |
Why?
| | Carcinoma, Basal Cell | 2 | 2017 | 75 | 0.400 |
Why?
| | Abnormalities, Multiple | 3 | 2014 | 189 | 0.390 |
Why?
| | Proteomics | 2 | 2016 | 1111 | 0.390 |
Why?
| | Eyelids | 2 | 2009 | 37 | 0.390 |
Why?
| | Keratin-10 | 8 | 2016 | 8 | 0.390 |
Why?
| | 9,10-Dimethyl-1,2-benzanthracene | 17 | 2010 | 24 | 0.390 |
Why?
| | Wnt Signaling Pathway | 2 | 2024 | 192 | 0.390 |
Why?
| | Transcription, Genetic | 23 | 2017 | 1457 | 0.380 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2012 | 36 | 0.380 |
Why?
| | DNA Primers | 13 | 2010 | 515 | 0.380 |
Why?
| | Cleft Lip | 2 | 2009 | 52 | 0.380 |
Why?
| | Melanoma, Experimental | 3 | 1998 | 114 | 0.380 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2012 | 430 | 0.370 |
Why?
| | Cleft Palate | 2 | 2009 | 68 | 0.370 |
Why?
| | Carcinogens | 12 | 2010 | 125 | 0.370 |
Why?
| | Oncogene Proteins v-fos | 6 | 1999 | 11 | 0.370 |
Why?
| | Mutation, Missense | 3 | 2016 | 341 | 0.370 |
Why?
| | Gene Transfer Techniques | 4 | 2002 | 170 | 0.370 |
Why?
| | Wound Healing | 6 | 2010 | 331 | 0.360 |
Why?
| | Apoptosis | 9 | 2012 | 2553 | 0.350 |
Why?
| | Calcium | 12 | 2010 | 1199 | 0.350 |
Why?
| | Centrosome | 4 | 2012 | 71 | 0.340 |
Why?
| | Hyperplasia | 12 | 2002 | 175 | 0.340 |
Why?
| | Proteins | 3 | 2016 | 1009 | 0.340 |
Why?
| | Pedigree | 11 | 2000 | 514 | 0.340 |
Why?
| | RNA, Messenger | 35 | 2016 | 2833 | 0.330 |
Why?
| | Integrases | 5 | 2004 | 120 | 0.330 |
Why?
| | Alleles | 7 | 2016 | 891 | 0.330 |
Why?
| | Gene Targeting | 5 | 2008 | 81 | 0.320 |
Why?
| | Stem Cell Niche | 1 | 2010 | 54 | 0.320 |
Why?
| | Epidermolysis Bullosa Simplex | 4 | 2004 | 10 | 0.320 |
Why?
| | Transcription Factor AP-2 | 2 | 2008 | 82 | 0.310 |
Why?
| | Immunotherapy | 3 | 2020 | 641 | 0.310 |
Why?
| | Genes, Recessive | 2 | 2021 | 78 | 0.310 |
Why?
| | Mice, Nude | 12 | 2016 | 698 | 0.300 |
Why?
| | Female | 74 | 2024 | 73304 | 0.300 |
Why?
| | Polymerase Chain Reaction | 13 | 2002 | 1062 | 0.290 |
Why?
| | Mice, Inbred Strains | 13 | 2010 | 409 | 0.280 |
Why?
| | Keratins, Type II | 1 | 2007 | 2 | 0.280 |
Why?
| | Adenoviridae | 3 | 1998 | 193 | 0.280 |
Why?
| | Fluorescent Antibody Technique | 19 | 2004 | 390 | 0.270 |
Why?
| | Aurora Kinases | 3 | 2012 | 27 | 0.270 |
Why?
| | Lipid Metabolism | 5 | 2018 | 518 | 0.270 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2007 | 18 | 0.270 |
Why?
| | Aurora Kinase A | 3 | 2012 | 56 | 0.270 |
Why?
| | Disease Progression | 6 | 2019 | 2757 | 0.260 |
Why?
| | Keratin-14 | 6 | 2012 | 15 | 0.260 |
Why?
| | Transcription Factor AP-1 | 3 | 2014 | 92 | 0.260 |
Why?
| | Mifepristone | 9 | 2009 | 64 | 0.260 |
Why?
| | Mice, Inbred BALB C | 17 | 2020 | 1272 | 0.260 |
Why?
| | Skin Transplantation | 6 | 2024 | 85 | 0.250 |
Why?
| | Amino Acid Substitution | 4 | 2000 | 307 | 0.250 |
Why?
| | Proto-Oncogenes | 1 | 2006 | 29 | 0.250 |
Why?
| | Ichthyosiform Erythroderma, Congenital | 2 | 2018 | 6 | 0.250 |
Why?
| | Models, Biological | 8 | 2016 | 1783 | 0.250 |
Why?
| | Genes, Reporter | 4 | 2009 | 269 | 0.250 |
Why?
| | Homeostasis | 3 | 2020 | 621 | 0.240 |
Why?
| | Male | 50 | 2024 | 67762 | 0.240 |
Why?
| | Kelch-Like ECH-Associated Protein 1 | 3 | 2016 | 12 | 0.240 |
Why?
| | Cell Line | 14 | 2018 | 2847 | 0.240 |
Why?
| | Genomic Instability | 4 | 2011 | 53 | 0.240 |
Why?
| | Oncogene Protein p21(ras) | 4 | 2004 | 16 | 0.240 |
Why?
| | Mice, Inbred C57BL | 19 | 2015 | 5757 | 0.230 |
Why?
| | Gene Expression | 12 | 2015 | 1502 | 0.230 |
Why?
| | Intermediate Filaments | 6 | 2015 | 28 | 0.230 |
Why?
| | Keratin-1 | 2 | 2016 | 2 | 0.230 |
Why?
| | Skin Diseases, Vesiculobullous | 2 | 1999 | 18 | 0.230 |
Why?
| | Phosphodiesterase 4 Inhibitors | 1 | 2024 | 5 | 0.230 |
Why?
| | Lipids | 4 | 2018 | 672 | 0.230 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 5 | 2015 | 267 | 0.220 |
Why?
| | Mouth Neoplasms | 2 | 2004 | 120 | 0.220 |
Why?
| | Protein Precursors | 9 | 2006 | 134 | 0.220 |
Why?
| | Prenatal Diagnosis | 2 | 1998 | 201 | 0.220 |
Why?
| | ras Proteins | 4 | 2013 | 153 | 0.220 |
Why?
| | beta Catenin | 3 | 2020 | 253 | 0.220 |
Why?
| | Retinoids | 2 | 1997 | 34 | 0.220 |
Why?
| | Heterozygote | 4 | 2010 | 293 | 0.210 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2024 | 81 | 0.210 |
Why?
| | Cocarcinogenesis | 4 | 2000 | 14 | 0.210 |
Why?
| | Sequence Analysis, DNA | 6 | 2016 | 812 | 0.210 |
Why?
| | Lac Operon | 2 | 2000 | 44 | 0.200 |
Why?
| | Transduction, Genetic | 4 | 2009 | 127 | 0.200 |
Why?
| | Transfection | 10 | 2017 | 945 | 0.200 |
Why?
| | Proto-Oncogene Proteins | 5 | 2013 | 648 | 0.200 |
Why?
| | Antioxidants | 2 | 2020 | 584 | 0.200 |
Why?
| | Tongue | 2 | 2001 | 81 | 0.200 |
Why?
| | Oncogenes | 5 | 1994 | 116 | 0.200 |
Why?
| | Wnt Proteins | 3 | 2010 | 133 | 0.200 |
Why?
| | Cytoskeleton | 8 | 1994 | 191 | 0.200 |
Why?
| | Cilia | 2 | 2017 | 178 | 0.190 |
Why?
| | Epithelial Cells | 14 | 2006 | 1096 | 0.190 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 976 | 0.190 |
Why?
| | Alopecia | 4 | 2005 | 32 | 0.190 |
Why?
| | Cell Membrane | 7 | 2015 | 738 | 0.190 |
Why?
| | Hindlimb | 2 | 1999 | 128 | 0.190 |
Why?
| | Micromanipulation | 1 | 2002 | 14 | 0.190 |
Why?
| | Human Growth Hormone | 1 | 2002 | 48 | 0.190 |
Why?
| | Chile | 1 | 2021 | 24 | 0.180 |
Why?
| | Chromosome Mapping | 5 | 2016 | 523 | 0.180 |
Why?
| | Colombia | 1 | 2021 | 41 | 0.180 |
Why?
| | Hair Diseases | 1 | 2001 | 9 | 0.180 |
Why?
| | Nail Diseases | 1 | 2001 | 8 | 0.180 |
Why?
| | Permeability | 3 | 2016 | 161 | 0.180 |
Why?
| | Microscopy, Electron | 10 | 2002 | 443 | 0.180 |
Why?
| | Blister | 1 | 2001 | 41 | 0.180 |
Why?
| | I-kappa B Kinase | 4 | 2009 | 55 | 0.180 |
Why?
| | Molecular Imprinting | 1 | 2020 | 4 | 0.180 |
Why?
| | Mexico | 1 | 2021 | 225 | 0.170 |
Why?
| | Neoplasm Transplantation | 6 | 2016 | 257 | 0.170 |
Why?
| | Microscopy, Confocal | 1 | 2002 | 325 | 0.170 |
Why?
| | Carcinoma | 5 | 1995 | 240 | 0.170 |
Why?
| | Ceramides | 3 | 2016 | 118 | 0.170 |
Why?
| | RNA | 6 | 2018 | 921 | 0.170 |
Why?
| | Cloning, Molecular | 9 | 2002 | 534 | 0.170 |
Why?
| | Regenerative Medicine | 2 | 2019 | 49 | 0.170 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2008 | 283 | 0.170 |
Why?
| | Adult Stem Cells | 1 | 2020 | 40 | 0.170 |
Why?
| | Laser Capture Microdissection | 2 | 2017 | 33 | 0.160 |
Why?
| | Fibroblasts | 6 | 2024 | 996 | 0.160 |
Why?
| | Blotting, Western | 8 | 2007 | 1226 | 0.160 |
Why?
| | Cell Membrane Permeability | 1 | 2020 | 78 | 0.160 |
Why?
| | Molecular Weight | 15 | 1990 | 335 | 0.160 |
Why?
| | Papillomaviridae | 3 | 2016 | 125 | 0.160 |
Why?
| | Zebrafish Proteins | 1 | 2002 | 288 | 0.160 |
Why?
| | Bimatoprost | 1 | 2019 | 3 | 0.160 |
Why?
| | Genetic Linkage | 4 | 1999 | 297 | 0.160 |
Why?
| | Immunologic Surveillance | 1 | 2019 | 25 | 0.160 |
Why?
| | Antineoplastic Agents | 5 | 2016 | 2129 | 0.160 |
Why?
| | Precancerous Conditions | 4 | 2004 | 169 | 0.160 |
Why?
| | Guided Tissue Regeneration | 1 | 2019 | 13 | 0.160 |
Why?
| | Crosses, Genetic | 4 | 2010 | 137 | 0.160 |
Why?
| | Skin Aging | 2 | 1997 | 20 | 0.160 |
Why?
| | Alopecia Areata | 1 | 2019 | 13 | 0.160 |
Why?
| | Deafness | 1 | 2000 | 77 | 0.160 |
Why?
| | Arginine | 2 | 2007 | 271 | 0.150 |
Why?
| | Threonine | 1 | 1999 | 47 | 0.150 |
Why?
| | Asparagine | 1 | 1999 | 31 | 0.150 |
Why?
| | Thymidine Kinase | 2 | 1998 | 15 | 0.150 |
Why?
| | Zinc Finger Protein GLI1 | 2 | 2017 | 25 | 0.150 |
Why?
| | Janus Kinase Inhibitors | 1 | 2019 | 26 | 0.150 |
Why?
| | Ovalbumin | 7 | 1981 | 183 | 0.150 |
Why?
| | Caspase 14 | 1 | 2018 | 1 | 0.150 |
Why?
| | Tumor Cells, Cultured | 7 | 2016 | 955 | 0.150 |
Why?
| | Simplexvirus | 2 | 1998 | 80 | 0.150 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2020 | 872 | 0.150 |
Why?
| | Microscopy, Immunoelectron | 4 | 2016 | 46 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-jun | 2 | 1999 | 55 | 0.150 |
Why?
| | Cytoprotection | 1 | 2018 | 56 | 0.150 |
Why?
| | Cellular Reprogramming Techniques | 1 | 2018 | 11 | 0.140 |
Why?
| | Autoimmunity | 1 | 2024 | 908 | 0.140 |
Why?
| | Transplantation, Heterologous | 3 | 2011 | 194 | 0.140 |
Why?
| | Potoroidae | 2 | 2007 | 3 | 0.140 |
Why?
| | Caspase 3 | 2 | 2010 | 246 | 0.140 |
Why?
| | Oncogene Proteins, Viral | 2 | 1994 | 22 | 0.140 |
Why?
| | Gene Silencing | 2 | 2016 | 195 | 0.140 |
Why?
| | Mammary Glands, Animal | 2 | 2006 | 129 | 0.140 |
Why?
| | Desmosomes | 2 | 2016 | 21 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 3 | 2013 | 233 | 0.140 |
Why?
| | Receptors, Retinoic Acid | 1 | 1997 | 43 | 0.140 |
Why?
| | Protein Multimerization | 1 | 2018 | 192 | 0.130 |
Why?
| | Syndrome | 3 | 2009 | 358 | 0.130 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 1997 | 59 | 0.130 |
Why?
| | Mutagenesis, Site-Directed | 4 | 1999 | 375 | 0.130 |
Why?
| | Neovascularization, Pathologic | 1 | 1998 | 301 | 0.130 |
Why?
| | Glucosylceramides | 1 | 2016 | 6 | 0.130 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 329 | 0.130 |
Why?
| | Nucleic Acid Hybridization | 13 | 1991 | 190 | 0.130 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2016 | 26 | 0.130 |
Why?
| | Kallikreins | 1 | 2016 | 29 | 0.130 |
Why?
| | Exons | 2 | 2016 | 355 | 0.130 |
Why?
| | Recombinant Fusion Proteins | 2 | 1996 | 665 | 0.130 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2014 | 43 | 0.130 |
Why?
| | Gene Amplification | 2 | 2011 | 104 | 0.120 |
Why?
| | Side-Population Cells | 2 | 2013 | 8 | 0.120 |
Why?
| | SOXB1 Transcription Factors | 1 | 2016 | 62 | 0.120 |
Why?
| | Aldehyde Dehydrogenase | 2 | 2016 | 100 | 0.120 |
Why?
| | Cell Movement | 5 | 2019 | 967 | 0.120 |
Why?
| | Microscopy, Fluorescence | 5 | 2007 | 402 | 0.120 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2013 | 209 | 0.120 |
Why?
| | Amino Acid Motifs | 1 | 2016 | 225 | 0.120 |
Why?
| | Genes, Regulator | 2 | 1993 | 37 | 0.120 |
Why?
| | Bromodeoxyuridine | 3 | 2001 | 79 | 0.120 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2016 | 150 | 0.120 |
Why?
| | Cetuximab | 1 | 2015 | 98 | 0.120 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1999 | 405 | 0.120 |
Why?
| | Hematopoietic Stem Cells | 3 | 2015 | 406 | 0.120 |
Why?
| | Receptors, Progesterone | 3 | 2002 | 350 | 0.110 |
Why?
| | Hand Deformities, Congenital | 1 | 2014 | 7 | 0.110 |
Why?
| | Trachea | 4 | 1993 | 237 | 0.110 |
Why?
| | Chloracne | 1 | 2014 | 1 | 0.110 |
Why?
| | Cricetinae | 9 | 1994 | 289 | 0.110 |
Why?
| | Keratin-2 | 3 | 2000 | 3 | 0.110 |
Why?
| | RNA, Neoplasm | 6 | 1995 | 82 | 0.110 |
Why?
| | Dermis | 2 | 2010 | 33 | 0.110 |
Why?
| | Genes, Tumor Suppressor | 2 | 2004 | 86 | 0.110 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2014 | 67 | 0.110 |
Why?
| | Cellular Reprogramming | 1 | 2014 | 99 | 0.110 |
Why?
| | Transcriptional Activation | 4 | 2007 | 378 | 0.110 |
Why?
| | Embryonic and Fetal Development | 3 | 2002 | 97 | 0.100 |
Why?
| | Hormones | 2 | 1994 | 143 | 0.100 |
Why?
| | Recombination, Genetic | 2 | 2008 | 204 | 0.100 |
Why?
| | Smad4 Protein | 1 | 2013 | 38 | 0.100 |
Why?
| | Genetic Engineering | 2 | 2007 | 93 | 0.100 |
Why?
| | Nuclear Proteins | 3 | 2006 | 712 | 0.100 |
Why?
| | DNA Mutational Analysis | 3 | 2018 | 399 | 0.100 |
Why?
| | Vagina | 3 | 1994 | 187 | 0.100 |
Why?
| | Embryoid Bodies | 1 | 2013 | 8 | 0.100 |
Why?
| | Fatty Acid Transport Proteins | 1 | 2012 | 19 | 0.100 |
Why?
| | RNA Splice Sites | 1 | 2012 | 45 | 0.100 |
Why?
| | DNA Restriction Enzymes | 7 | 1998 | 52 | 0.100 |
Why?
| | Keratins, Hair-Specific | 1 | 2012 | 1 | 0.100 |
Why?
| | Models, Animal | 4 | 2013 | 384 | 0.100 |
Why?
| | Polymorphism, Restriction Fragment Length | 3 | 2004 | 68 | 0.100 |
Why?
| | Polyploidy | 1 | 2012 | 19 | 0.100 |
Why?
| | Macromolecular Substances | 7 | 1992 | 229 | 0.100 |
Why?
| | Cell Separation | 2 | 2007 | 318 | 0.100 |
Why?
| | Quinone Reductases | 2 | 2002 | 17 | 0.090 |
Why?
| | Fetal Diseases | 1 | 1994 | 173 | 0.090 |
Why?
| | RNA, Small Interfering | 3 | 2012 | 622 | 0.090 |
Why?
| | Binding Sites | 4 | 2006 | 1303 | 0.090 |
Why?
| | Carrier Proteins | 2 | 2003 | 771 | 0.090 |
Why?
| | Dermatology | 1 | 2014 | 127 | 0.090 |
Why?
| | Embryo, Mammalian | 3 | 2010 | 232 | 0.090 |
Why?
| | Immunohistochemistry | 14 | 2007 | 1738 | 0.090 |
Why?
| | Cancer Vaccines | 3 | 1998 | 172 | 0.090 |
Why?
| | MicroRNAs | 2 | 2015 | 692 | 0.090 |
Why?
| | Cerebellar Ataxia | 1 | 2011 | 10 | 0.090 |
Why?
| | Immunocompetence | 1 | 2011 | 42 | 0.090 |
Why?
| | Regulatory Sequences, Nucleic Acid | 3 | 1999 | 91 | 0.090 |
Why?
| | Cell Count | 2 | 1991 | 324 | 0.090 |
Why?
| | Sebaceous Glands | 1 | 2010 | 5 | 0.090 |
Why?
| | Keratolytic Agents | 1 | 2010 | 5 | 0.090 |
Why?
| | Epitopes | 3 | 1997 | 479 | 0.090 |
Why?
| | Integrins | 1 | 2011 | 95 | 0.090 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 32 | 0.090 |
Why?
| | Decidua | 1 | 2010 | 24 | 0.090 |
Why?
| | Introns | 4 | 2004 | 258 | 0.090 |
Why?
| | Carcinogenesis | 3 | 2021 | 217 | 0.090 |
Why?
| | Ribosomal Proteins | 1 | 2011 | 93 | 0.090 |
Why?
| | Tumor Microenvironment | 1 | 2015 | 674 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-fos | 3 | 1999 | 185 | 0.090 |
Why?
| | Nevus | 1 | 2010 | 26 | 0.090 |
Why?
| | Polymorphism, Genetic | 1 | 1993 | 660 | 0.080 |
Why?
| | Adenocarcinoma, Sebaceous | 1 | 2010 | 1 | 0.080 |
Why?
| | Sebaceous Gland Neoplasms | 1 | 2010 | 2 | 0.080 |
Why?
| | Genetic Techniques | 2 | 2005 | 64 | 0.080 |
Why?
| | Biomarkers, Tumor | 7 | 2009 | 1276 | 0.080 |
Why?
| | Aneuploidy | 2 | 2007 | 89 | 0.080 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2012 | 801 | 0.080 |
Why?
| | Caspase 7 | 1 | 2010 | 22 | 0.080 |
Why?
| | In Situ Nick-End Labeling | 2 | 2007 | 124 | 0.080 |
Why?
| | Osteoblasts | 1 | 2011 | 126 | 0.080 |
Why?
| | Genotype | 4 | 2015 | 1916 | 0.080 |
Why?
| | Neoplasms | 2 | 2006 | 2671 | 0.080 |
Why?
| | Organ Specificity | 4 | 2007 | 305 | 0.080 |
Why?
| | Arachidonate 12-Lipoxygenase | 1 | 2009 | 18 | 0.080 |
Why?
| | Liver Regeneration | 1 | 2010 | 46 | 0.080 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 1990 | 68 | 0.080 |
Why?
| | Teratoma | 1 | 2010 | 114 | 0.080 |
Why?
| | Uterus | 1 | 2010 | 215 | 0.080 |
Why?
| | Disease Susceptibility | 5 | 2006 | 347 | 0.080 |
Why?
| | Oviducts | 9 | 1982 | 16 | 0.080 |
Why?
| | Collagen | 2 | 1988 | 452 | 0.080 |
Why?
| | Gene Expression Profiling | 4 | 2015 | 1774 | 0.080 |
Why?
| | Osteogenesis | 1 | 2011 | 188 | 0.080 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2015 | 1079 | 0.080 |
Why?
| | Non-Fibrillar Collagens | 1 | 1988 | 2 | 0.080 |
Why?
| | Mitochondria | 1 | 2015 | 948 | 0.080 |
Why?
| | Pemphigoid, Bullous | 1 | 1988 | 9 | 0.080 |
Why?
| | Muscle, Smooth | 1 | 1990 | 155 | 0.080 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 622 | 0.080 |
Why?
| | Down-Regulation | 4 | 2009 | 657 | 0.080 |
Why?
| | Selection, Genetic | 1 | 2011 | 273 | 0.080 |
Why?
| | Receptor, Notch1 | 2 | 2006 | 64 | 0.080 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 327 | 0.070 |
Why?
| | Spindle Apparatus | 1 | 2009 | 102 | 0.070 |
Why?
| | beta-Galactosidase | 2 | 1999 | 78 | 0.070 |
Why?
| | Foot | 1 | 2009 | 96 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2012 | 443 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2005 | 121 | 0.070 |
Why?
| | Hand | 1 | 2009 | 156 | 0.070 |
Why?
| | Genes, Lethal | 2 | 2008 | 30 | 0.070 |
Why?
| | Integrin beta1 | 2 | 2013 | 25 | 0.070 |
Why?
| | Olfactory Mucosa | 1 | 2008 | 38 | 0.070 |
Why?
| | Hoof and Claw | 1 | 2007 | 5 | 0.070 |
Why?
| | Cell Death | 1 | 2009 | 374 | 0.070 |
Why?
| | Bone Marrow | 2 | 2015 | 286 | 0.070 |
Why?
| | Protein Structure, Tertiary | 2 | 2007 | 861 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2010 | 455 | 0.070 |
Why?
| | Langerhans Cells | 2 | 1997 | 12 | 0.070 |
Why?
| | Protein Conformation | 6 | 1992 | 934 | 0.070 |
Why?
| | Adult | 10 | 2020 | 37929 | 0.070 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1998 | 152 | 0.070 |
Why?
| | Growth Substances | 2 | 1999 | 147 | 0.070 |
Why?
| | Cytoplasmic Granules | 4 | 2002 | 93 | 0.070 |
Why?
| | Caspase 9 | 1 | 2007 | 57 | 0.070 |
Why?
| | Cell Line, Tumor | 5 | 2015 | 3412 | 0.070 |
Why?
| | Species Specificity | 3 | 2000 | 585 | 0.070 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 1999 | 38 | 0.070 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2006 | 17 | 0.070 |
Why?
| | Neoplasm Proteins | 2 | 2006 | 434 | 0.070 |
Why?
| | Coculture Techniques | 2 | 2024 | 239 | 0.070 |
Why?
| | Cell Adhesion | 3 | 2015 | 466 | 0.070 |
Why?
| | Interleukin-1alpha | 2 | 2020 | 58 | 0.060 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2007 | 67 | 0.060 |
Why?
| | Ganciclovir | 2 | 1998 | 53 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1692 | 0.060 |
Why?
| | Twist-Related Protein 1 | 1 | 2006 | 9 | 0.060 |
Why?
| | Biological Assay | 1 | 2007 | 124 | 0.060 |
Why?
| | Glycine | 1 | 2007 | 176 | 0.060 |
Why?
| | Mice, SCID | 3 | 2013 | 367 | 0.060 |
Why?
| | Blotting, Northern | 6 | 1992 | 201 | 0.060 |
Why?
| | Phorbols | 1 | 1985 | 10 | 0.060 |
Why?
| | Lymphatic Metastasis | 1 | 2007 | 352 | 0.060 |
Why?
| | Darier Disease | 1 | 2005 | 2 | 0.060 |
Why?
| | Antibodies | 2 | 1985 | 410 | 0.060 |
Why?
| | Stomach | 2 | 2006 | 110 | 0.060 |
Why?
| | Autoantigens | 1 | 1988 | 430 | 0.060 |
Why?
| | Nucleic Acid Precursors | 3 | 1980 | 24 | 0.060 |
Why?
| | Models, Genetic | 3 | 2008 | 600 | 0.060 |
Why?
| | Protein Structure, Secondary | 2 | 1999 | 374 | 0.060 |
Why?
| | Enzyme Activation | 1 | 2007 | 810 | 0.060 |
Why?
| | Flow Cytometry | 2 | 2007 | 1178 | 0.060 |
Why?
| | Recombinant Proteins | 2 | 1999 | 1353 | 0.060 |
Why?
| | Cyclins | 2 | 1996 | 91 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2012 | 1317 | 0.060 |
Why?
| | Skin Abnormalities | 2 | 2002 | 12 | 0.060 |
Why?
| | Cell Cycle Proteins | 2 | 2006 | 617 | 0.060 |
Why?
| | Cell Adhesion Molecules | 1 | 2006 | 181 | 0.060 |
Why?
| | Retinal Dehydrogenase | 2 | 2016 | 29 | 0.060 |
Why?
| | Embryonic Development | 1 | 2005 | 119 | 0.060 |
Why?
| | Nerve Tissue Proteins | 1 | 1988 | 596 | 0.060 |
Why?
| | Melanins | 1 | 2024 | 18 | 0.060 |
Why?
| | RNA Interference | 3 | 2013 | 469 | 0.060 |
Why?
| | Cyclopropanes | 1 | 2024 | 90 | 0.060 |
Why?
| | Calcineurin | 1 | 2005 | 108 | 0.060 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 1990 | 345 | 0.060 |
Why?
| | Homeodomain Proteins | 2 | 2006 | 506 | 0.060 |
Why?
| | Boron Compounds | 1 | 2024 | 27 | 0.060 |
Why?
| | Sequence Analysis, RNA | 2 | 2017 | 452 | 0.050 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2024 | 10 | 0.050 |
Why?
| | Transglutaminases | 3 | 1995 | 156 | 0.050 |
Why?
| | Blotting, Southern | 3 | 2001 | 73 | 0.050 |
Why?
| | United States | 1 | 2021 | 14841 | 0.050 |
Why?
| | Aminopyridines | 1 | 2024 | 98 | 0.050 |
Why?
| | In Vitro Techniques | 4 | 2013 | 1092 | 0.050 |
Why?
| | Pregnancy | 5 | 2010 | 6763 | 0.050 |
Why?
| | Benzamides | 1 | 2024 | 216 | 0.050 |
Why?
| | Receptors, Cell Surface | 2 | 2005 | 385 | 0.050 |
Why?
| | Gene Editing | 1 | 2024 | 80 | 0.050 |
Why?
| | Transplantation, Autologous | 1 | 2024 | 238 | 0.050 |
Why?
| | Tissue Distribution | 2 | 2002 | 332 | 0.050 |
Why?
| | Body Weight | 2 | 2011 | 985 | 0.050 |
Why?
| | Time Factors | 5 | 2004 | 6828 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2024 | 125 | 0.050 |
Why?
| | Vimentin | 4 | 1994 | 52 | 0.050 |
Why?
| | Molecular Structure | 2 | 1994 | 489 | 0.050 |
Why?
| | Vitamin K 3 | 1 | 2002 | 3 | 0.050 |
Why?
| | Biomarkers | 5 | 2004 | 4149 | 0.050 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2024 | 227 | 0.050 |
Why?
| | Genetic Variation | 2 | 1998 | 991 | 0.050 |
Why?
| | S100 Proteins | 2 | 2000 | 37 | 0.050 |
Why?
| | Dacarbazine | 2 | 2012 | 98 | 0.050 |
Why?
| | Keratin-15 | 1 | 2002 | 16 | 0.050 |
Why?
| | Bioreactors | 1 | 2002 | 42 | 0.050 |
Why?
| | Keratin-5 | 1 | 2002 | 50 | 0.050 |
Why?
| | Mesocricetus | 5 | 1993 | 39 | 0.050 |
Why?
| | Isomerism | 1 | 2001 | 56 | 0.050 |
Why?
| | Immunoenzyme Techniques | 4 | 1993 | 219 | 0.050 |
Why?
| | Starvation | 1 | 2001 | 22 | 0.050 |
Why?
| | 3T3 Cells | 3 | 2013 | 163 | 0.050 |
Why?
| | Vitamin A Deficiency | 3 | 1993 | 26 | 0.050 |
Why?
| | Luteolytic Agents | 1 | 2001 | 1 | 0.040 |
Why?
| | Mouth Diseases | 1 | 2001 | 45 | 0.040 |
Why?
| | Lasers | 1 | 2002 | 130 | 0.040 |
Why?
| | Bone and Bones | 1 | 2004 | 317 | 0.040 |
Why?
| | Administration, Topical | 3 | 1997 | 151 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2004 | 434 | 0.040 |
Why?
| | Benzo(a)pyrene | 1 | 2000 | 8 | 0.040 |
Why?
| | Response Elements | 2 | 2012 | 91 | 0.040 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2000 | 32 | 0.040 |
Why?
| | Nuclear Localization Signals | 1 | 2000 | 18 | 0.040 |
Why?
| | Frameshift Mutation | 1 | 2000 | 32 | 0.040 |
Why?
| | Autoantibodies | 1 | 1988 | 1496 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 2000 | 52 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2001 | 385 | 0.040 |
Why?
| | Netherton Syndrome | 1 | 2020 | 3 | 0.040 |
Why?
| | Dermatitis, Exfoliative | 1 | 2020 | 4 | 0.040 |
Why?
| | Cell Survival | 3 | 2013 | 1120 | 0.040 |
Why?
| | Adaptation, Biological | 1 | 2000 | 56 | 0.040 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2020 | 50 | 0.040 |
Why?
| | Chickens | 9 | 1995 | 191 | 0.040 |
Why?
| | Rats | 5 | 1994 | 5647 | 0.040 |
Why?
| | Immunoblotting | 4 | 2003 | 308 | 0.040 |
Why?
| | rho GTP-Binding Proteins | 1 | 2020 | 60 | 0.040 |
Why?
| | Zebrafish | 1 | 2004 | 499 | 0.040 |
Why?
| | Cell Nucleus | 7 | 2004 | 620 | 0.040 |
Why?
| | Repressor Proteins | 2 | 2013 | 427 | 0.040 |
Why?
| | Estrenes | 1 | 1999 | 16 | 0.040 |
Why?
| | DNA, Complementary | 2 | 2003 | 272 | 0.040 |
Why?
| | Kidney | 1 | 2007 | 1468 | 0.040 |
Why?
| | DNA, Neoplasm | 3 | 1995 | 164 | 0.040 |
Why?
| | Restriction Mapping | 1 | 1999 | 77 | 0.040 |
Why?
| | Genomic Library | 1 | 1999 | 18 | 0.040 |
Why?
| | Genetic Carrier Screening | 1 | 1999 | 28 | 0.040 |
Why?
| | Phototherapy | 1 | 2019 | 39 | 0.040 |
Why?
| | Forelimb | 1 | 1999 | 29 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 56 | 0.040 |
Why?
| | DNA Damage | 2 | 2012 | 420 | 0.040 |
Why?
| | RNA, Heterogeneous Nuclear | 1 | 1978 | 5 | 0.040 |
Why?
| | Fungal Proteins | 1 | 1999 | 123 | 0.040 |
Why?
| | Sequence Analysis | 1 | 1998 | 36 | 0.040 |
Why?
| | Protein Transport | 1 | 2000 | 445 | 0.040 |
Why?
| | Thrombospondin 1 | 1 | 1998 | 27 | 0.040 |
Why?
| | Reference Values | 3 | 2002 | 816 | 0.040 |
Why?
| | Dimerization | 1 | 1999 | 199 | 0.040 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 1998 | 79 | 0.040 |
Why?
| | Endothelial Growth Factors | 1 | 1998 | 64 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2011 | 2253 | 0.040 |
Why?
| | Lymphokines | 1 | 1998 | 131 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2011 | 767 | 0.040 |
Why?
| | Peptides | 1 | 1984 | 985 | 0.040 |
Why?
| | Body Patterning | 1 | 1999 | 132 | 0.040 |
Why?
| | Mutagenesis, Insertional | 1 | 1998 | 65 | 0.040 |
Why?
| | Genes, bcl-2 | 1 | 1998 | 21 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2002 | 956 | 0.040 |
Why?
| | Neovascularization, Physiologic | 1 | 1999 | 179 | 0.040 |
Why?
| | Psoriasis | 2 | 1996 | 102 | 0.030 |
Why?
| | Age of Onset | 1 | 1999 | 518 | 0.030 |
Why?
| | Gamma Rays | 1 | 1998 | 57 | 0.030 |
Why?
| | Retinoic Acid Receptor alpha | 1 | 1997 | 17 | 0.030 |
Why?
| | Thymus Gland | 1 | 1998 | 312 | 0.030 |
Why?
| | Oxazines | 1 | 1997 | 30 | 0.030 |
Why?
| | Retinoid X Receptors | 1 | 1997 | 39 | 0.030 |
Why?
| | Antigens, Neoplasm | 2 | 1997 | 319 | 0.030 |
Why?
| | Epidermal Growth Factor | 3 | 1993 | 177 | 0.030 |
Why?
| | Mitotic Index | 1 | 1997 | 25 | 0.030 |
Why?
| | Protein Binding | 3 | 2009 | 2224 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2006 | 2426 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2000 | 810 | 0.030 |
Why?
| | Metaplasia | 3 | 1993 | 60 | 0.030 |
Why?
| | Receptors, Calcitriol | 1 | 1997 | 55 | 0.030 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 1997 | 76 | 0.030 |
Why?
| | Clinical Trials, Phase I as Topic | 1 | 1997 | 50 | 0.030 |
Why?
| | Luciferases | 2 | 2009 | 150 | 0.030 |
Why?
| | Hybrid Cells | 2 | 1994 | 49 | 0.030 |
Why?
| | Carcinogenicity Tests | 2 | 1994 | 10 | 0.030 |
Why?
| | Hypertrophy | 1 | 1997 | 133 | 0.030 |
Why?
| | Interleukin-2 | 1 | 1998 | 455 | 0.030 |
Why?
| | Organ Culture Techniques | 4 | 1990 | 156 | 0.030 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 1987 | 113 | 0.030 |
Why?
| | Body Temperature | 1 | 1997 | 222 | 0.030 |
Why?
| | Hyaluronan Receptors | 1 | 2016 | 102 | 0.030 |
Why?
| | Extremities | 1 | 1997 | 131 | 0.030 |
Why?
| | Rats, Inbred F344 | 2 | 1993 | 265 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 1998 | 545 | 0.030 |
Why?
| | Spheroids, Cellular | 1 | 2016 | 76 | 0.030 |
Why?
| | Kinetics | 5 | 1994 | 1670 | 0.030 |
Why?
| | Rabbits | 2 | 1996 | 794 | 0.030 |
Why?
| | Phospholipids | 1 | 1997 | 223 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 1998 | 658 | 0.030 |
Why?
| | Maximum Tolerated Dose | 1 | 2015 | 199 | 0.030 |
Why?
| | Fluorescent Dyes | 1 | 1997 | 321 | 0.030 |
Why?
| | Biopsy | 2 | 1997 | 1129 | 0.030 |
Why?
| | PAX3 Transcription Factor | 1 | 2015 | 17 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1995 | 155 | 0.030 |
Why?
| | Paired Box Transcription Factors | 1 | 2015 | 46 | 0.030 |
Why?
| | Inhibins | 1 | 1995 | 44 | 0.030 |
Why?
| | Interleukins | 1 | 1997 | 250 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2015 | 68 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 353 | 0.030 |
Why?
| | Benzoates | 1 | 1995 | 43 | 0.030 |
Why?
| | Cantharidin | 1 | 1994 | 1 | 0.030 |
Why?
| | Ainhum | 1 | 2014 | 1 | 0.030 |
Why?
| | Tetrahydronaphthalenes | 1 | 1995 | 29 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 346 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2015 | 67 | 0.030 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 1997 | 210 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 1998 | 1236 | 0.030 |
Why?
| | DNA Probes, HPV | 1 | 1994 | 1 | 0.030 |
Why?
| | Evaluation Studies as Topic | 1 | 1994 | 180 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1995 | 343 | 0.030 |
Why?
| | Staining and Labeling | 2 | 2010 | 150 | 0.030 |
Why?
| | Actin Cytoskeleton | 1 | 1995 | 103 | 0.030 |
Why?
| | Ornithine Decarboxylase | 1 | 1994 | 10 | 0.030 |
Why?
| | Epigen | 1 | 2014 | 1 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 828 | 0.030 |
Why?
| | Secretory Leukocyte Peptidase Inhibitor | 1 | 2014 | 6 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 686 | 0.030 |
Why?
| | Open Reading Frames | 1 | 1994 | 123 | 0.030 |
Why?
| | Middle Aged | 5 | 2020 | 33479 | 0.030 |
Why?
| | Simian virus 40 | 1 | 1993 | 24 | 0.030 |
Why?
| | TATA Box | 1 | 1993 | 24 | 0.030 |
Why?
| | Collagen Type IV | 1 | 2014 | 28 | 0.030 |
Why?
| | Chorionic Villi | 1 | 1994 | 25 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2007 | 2526 | 0.030 |
Why?
| | alpha Catenin | 1 | 2013 | 11 | 0.030 |
Why?
| | Laminin | 1 | 1994 | 72 | 0.030 |
Why?
| | Multigene Family | 1 | 1994 | 198 | 0.030 |
Why?
| | Butylhydroxybutylnitrosamine | 1 | 1993 | 6 | 0.030 |
Why?
| | Cholecalciferol | 1 | 1994 | 60 | 0.030 |
Why?
| | Clone Cells | 2 | 2010 | 265 | 0.030 |
Why?
| | Cell Dedifferentiation | 1 | 2013 | 32 | 0.030 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2013 | 49 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2014 | 245 | 0.030 |
Why?
| | Antigens, CD | 1 | 2016 | 521 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2020 | 10811 | 0.030 |
Why?
| | Mice, Inbred CBA | 1 | 2013 | 54 | 0.030 |
Why?
| | Ovariectomy | 1 | 1994 | 152 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2009 | 6079 | 0.030 |
Why?
| | Viruses | 1 | 1994 | 113 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2016 | 412 | 0.030 |
Why?
| | Sulfur Radioisotopes | 2 | 1990 | 15 | 0.030 |
Why?
| | Protein Biosynthesis | 6 | 1991 | 433 | 0.030 |
Why?
| | DNA Probes | 2 | 1992 | 60 | 0.030 |
Why?
| | Collagen Type I | 1 | 2014 | 136 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2016 | 614 | 0.030 |
Why?
| | Glycoproteins | 1 | 1995 | 342 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2013 | 183 | 0.030 |
Why?
| | Chromosomes, Mammalian | 1 | 2012 | 26 | 0.020 |
Why?
| | Lentivirus | 1 | 2013 | 56 | 0.020 |
Why?
| | Diseases in Twins | 1 | 1994 | 169 | 0.020 |
Why?
| | Aldehyde Oxidoreductases | 1 | 2012 | 27 | 0.020 |
Why?
| | Forecasting | 1 | 1994 | 389 | 0.020 |
Why?
| | Breast | 1 | 1993 | 151 | 0.020 |
Why?
| | Child | 3 | 2020 | 21935 | 0.020 |
Why?
| | Egg Proteins | 3 | 1982 | 17 | 0.020 |
Why?
| | Serine | 1 | 1993 | 141 | 0.020 |
Why?
| | Bacteriophage lambda | 1 | 1993 | 88 | 0.020 |
Why?
| | Limb Buds | 2 | 2004 | 23 | 0.020 |
Why?
| | Coloring Agents | 1 | 2012 | 87 | 0.020 |
Why?
| | Cysteine | 1 | 1993 | 204 | 0.020 |
Why?
| | Isoenzymes | 1 | 2012 | 304 | 0.020 |
Why?
| | Tritium | 3 | 1994 | 76 | 0.020 |
Why?
| | Myoepithelioma | 1 | 1991 | 4 | 0.020 |
Why?
| | Mutagenicity Tests | 1 | 2011 | 11 | 0.020 |
Why?
| | Gene Knock-In Techniques | 1 | 2011 | 56 | 0.020 |
Why?
| | Avian Leukosis Virus | 1 | 2011 | 6 | 0.020 |
Why?
| | Age Factors | 2 | 1996 | 3295 | 0.020 |
Why?
| | Integrin-Binding Sialoprotein | 1 | 2011 | 5 | 0.020 |
Why?
| | Ovomucin | 2 | 1982 | 6 | 0.020 |
Why?
| | Rodent Diseases | 1 | 1991 | 28 | 0.020 |
Why?
| | Biological Evolution | 2 | 1985 | 474 | 0.020 |
Why?
| | Moloney murine leukemia virus | 1 | 1991 | 13 | 0.020 |
Why?
| | Haploinsufficiency | 1 | 2011 | 56 | 0.020 |
Why?
| | Hyperpigmentation | 1 | 2011 | 26 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2012 | 268 | 0.020 |
Why?
| | Osteocalcin | 1 | 2011 | 37 | 0.020 |
Why?
| | Proteome | 1 | 2015 | 472 | 0.020 |
Why?
| | Progesterone | 2 | 2010 | 254 | 0.020 |
Why?
| | Paclitaxel | 1 | 2012 | 230 | 0.020 |
Why?
| | Infant | 2 | 2009 | 9465 | 0.020 |
Why?
| | Wnt4 Protein | 1 | 2010 | 18 | 0.020 |
Why?
| | Growth Disorders | 1 | 2011 | 86 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1946 | 0.020 |
Why?
| | Embryo Implantation | 1 | 2010 | 30 | 0.020 |
Why?
| | Immunosorbent Techniques | 2 | 1987 | 21 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 601 | 0.020 |
Why?
| | Swine | 1 | 1993 | 775 | 0.020 |
Why?
| | Cytokines | 2 | 2015 | 2085 | 0.020 |
Why?
| | Pigmentation | 1 | 2010 | 52 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 1997 | 900 | 0.020 |
Why?
| | Mitosis | 1 | 2011 | 192 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1710 | 0.020 |
Why?
| | Urinary Bladder Neoplasms | 1 | 1993 | 252 | 0.020 |
Why?
| | Estrogens | 4 | 1982 | 367 | 0.020 |
Why?
| | DNA Repair | 1 | 2012 | 231 | 0.020 |
Why?
| | Phospholipases A2 | 1 | 2010 | 80 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 971 | 0.020 |
Why?
| | Child, Preschool | 2 | 2009 | 11074 | 0.020 |
Why?
| | Animals, Wild | 1 | 1990 | 59 | 0.020 |
Why?
| | Adenoma, Pleomorphic | 1 | 1990 | 11 | 0.020 |
Why?
| | Parotid Neoplasms | 1 | 1990 | 16 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 1990 | 92 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 1994 | 1483 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 1998 | 1996 | 0.020 |
Why?
| | Smad3 Protein | 1 | 2009 | 43 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2009 | 90 | 0.020 |
Why?
| | Arachidonic Acid | 1 | 2010 | 120 | 0.020 |
Why?
| | Liver | 2 | 2002 | 1943 | 0.020 |
Why?
| | Amino Acids | 4 | 2002 | 497 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 1990 | 269 | 0.020 |
Why?
| | Anemia | 1 | 2011 | 170 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 1999 | 5131 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2009 | 138 | 0.020 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2009 | 86 | 0.020 |
Why?
| | Imidazoles | 1 | 2010 | 238 | 0.020 |
Why?
| | Dinoprostone | 1 | 2010 | 191 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2010 | 175 | 0.020 |
Why?
| | Diethylstilbestrol | 2 | 1979 | 9 | 0.020 |
Why?
| | Dystonin | 1 | 1988 | 1 | 0.020 |
Why?
| | Ameloblastoma | 1 | 1988 | 5 | 0.020 |
Why?
| | Cellular Senescence | 1 | 2010 | 189 | 0.020 |
Why?
| | Lactation | 1 | 1990 | 181 | 0.020 |
Why?
| | Cell Communication | 1 | 2010 | 315 | 0.020 |
Why?
| | Methionine | 1 | 1989 | 160 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3556 | 0.020 |
Why?
| | Tissue Scaffolds | 1 | 2011 | 211 | 0.020 |
Why?
| | gamma-Glutamyltransferase | 1 | 1988 | 43 | 0.020 |
Why?
| | Vitamin A | 2 | 1986 | 58 | 0.020 |
Why?
| | Piperazines | 1 | 2010 | 350 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 510 | 0.020 |
Why?
| | Isoelectric Point | 1 | 1987 | 25 | 0.020 |
Why?
| | Antigens, Differentiation | 1 | 1988 | 83 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 852 | 0.020 |
Why?
| | Organoids | 1 | 1988 | 112 | 0.020 |
Why?
| | Survival Analysis | 1 | 2010 | 1325 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 1988 | 107 | 0.020 |
Why?
| | Interferon-gamma | 1 | 1990 | 789 | 0.020 |
Why?
| | Antigens, Ly | 1 | 1987 | 44 | 0.020 |
Why?
| | Harvey murine sarcoma virus | 1 | 1986 | 1 | 0.020 |
Why?
| | Dimethyl Sulfoxide | 1 | 1987 | 41 | 0.020 |
Why?
| | Olfactory Bulb | 1 | 2008 | 93 | 0.020 |
Why?
| | Occludin | 1 | 2006 | 11 | 0.020 |
Why?
| | LIM Domain Proteins | 1 | 2006 | 21 | 0.020 |
Why?
| | Claudin-1 | 1 | 2006 | 15 | 0.020 |
Why?
| | Minichromosome Maintenance Complex Component 7 | 1 | 2006 | 4 | 0.020 |
Why?
| | Interleukin-6 | 1 | 1990 | 778 | 0.020 |
Why?
| | Receptors, Steroid | 1 | 2006 | 50 | 0.020 |
Why?
| | Immunoassay | 1 | 1987 | 115 | 0.020 |
Why?
| | Chemistry | 1 | 1985 | 45 | 0.020 |
Why?
| | Chemical Phenomena | 1 | 1985 | 83 | 0.020 |
Why?
| | Fluocinolone Acetonide | 1 | 1985 | 19 | 0.010 |
Why?
| | X-Ray Diffraction | 1 | 1985 | 104 | 0.010 |
Why?
| | Calcium-Binding Proteins | 1 | 1986 | 218 | 0.010 |
Why?
| | Microscopy, Electron, Scanning | 1 | 1985 | 201 | 0.010 |
Why?
| | HeLa Cells | 1 | 2007 | 636 | 0.010 |
Why?
| | Phosphorylation | 1 | 2009 | 1759 | 0.010 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 1 | 2004 | 17 | 0.010 |
Why?
| | Cattle | 2 | 1988 | 984 | 0.010 |
Why?
| | Calcineurin Inhibitors | 1 | 2005 | 72 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2012 | 2189 | 0.010 |
Why?
| | YY1 Transcription Factor | 1 | 2004 | 25 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 1987 | 465 | 0.010 |
Why?
| | NFATC Transcription Factors | 1 | 2005 | 95 | 0.010 |
Why?
| | Base Composition | 1 | 1984 | 78 | 0.010 |
Why?
| | Hormone Antagonists | 1 | 2004 | 34 | 0.010 |
Why?
| | Aged | 3 | 2020 | 23961 | 0.010 |
Why?
| | Thymidine | 2 | 1994 | 60 | 0.010 |
Why?
| | Antigen-Antibody Complex | 1 | 1984 | 90 | 0.010 |
Why?
| | Fibroblast Growth Factor 8 | 1 | 2004 | 27 | 0.010 |
Why?
| | Interleukin-1 | 1 | 1988 | 965 | 0.010 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 2004 | 67 | 0.010 |
Why?
| | Terminology as Topic | 1 | 1985 | 216 | 0.010 |
Why?
| | src-Family Kinases | 1 | 2004 | 92 | 0.010 |
Why?
| | Stomach Diseases | 1 | 2003 | 20 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 13209 | 0.010 |
Why?
| | Weaning | 1 | 2003 | 47 | 0.010 |
Why?
| | Antibodies, Monoclonal | 2 | 1990 | 1430 | 0.010 |
Why?
| | Craniofacial Abnormalities | 1 | 2004 | 72 | 0.010 |
Why?
| | Esophageal Diseases | 1 | 2003 | 28 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 1987 | 528 | 0.010 |
Why?
| | Mice, Hairless | 2 | 1994 | 60 | 0.010 |
Why?
| | Adolescent | 2 | 2020 | 21513 | 0.010 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2003 | 66 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2008 | 1050 | 0.010 |
Why?
| | Fibroblast Growth Factors | 1 | 2004 | 172 | 0.010 |
Why?
| | Aging | 1 | 1993 | 1864 | 0.010 |
Why?
| | Cheek | 2 | 1993 | 17 | 0.010 |
Why?
| | Fertility | 1 | 2002 | 160 | 0.010 |
Why?
| | RNA, Small Nuclear | 1 | 1981 | 37 | 0.010 |
Why?
| | Mice, Inbred A | 1 | 2000 | 49 | 0.010 |
Why?
| | Biotransformation | 1 | 2000 | 65 | 0.010 |
Why?
| | Peptide Fragments | 1 | 1984 | 706 | 0.010 |
Why?
| | Risk Factors | 1 | 1994 | 10388 | 0.010 |
Why?
| | Sequence Homology | 1 | 1999 | 40 | 0.010 |
Why?
| | Limb Deformities, Congenital | 1 | 1999 | 14 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 2057 | 0.010 |
Why?
| | Neurons | 1 | 2008 | 1590 | 0.010 |
Why?
| | Phosphorus Radioisotopes | 1 | 1978 | 30 | 0.010 |
Why?
| | Globins | 1 | 1978 | 22 | 0.010 |
Why?
| | Reticulocytes | 1 | 1978 | 18 | 0.010 |
Why?
| | Cholera Toxin | 2 | 1988 | 32 | 0.010 |
Why?
| | Polyribosomes | 1 | 1978 | 24 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 101 | 0.010 |
Why?
| | Antibody Specificity | 2 | 1989 | 189 | 0.010 |
Why?
| | DNA Fragmentation | 1 | 1998 | 41 | 0.010 |
Why?
| | Drug Stability | 1 | 1978 | 167 | 0.010 |
Why?
| | Isotope Labeling | 1 | 1978 | 81 | 0.010 |
Why?
| | RNA Polymerase II | 1 | 1981 | 324 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 336 | 0.010 |
Why?
| | Immunologic Techniques | 2 | 1986 | 40 | 0.010 |
Why?
| | Desmogleins | 1 | 1996 | 3 | 0.010 |
Why?
| | Desmoplakins | 1 | 1996 | 20 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 1998 | 417 | 0.010 |
Why?
| | Receptors, Estrogen | 1 | 1979 | 436 | 0.010 |
Why?
| | Follistatin | 1 | 1995 | 12 | 0.010 |
Why?
| | Activins | 1 | 1995 | 28 | 0.010 |
Why?
| | Vibrissae | 1 | 1995 | 10 | 0.010 |
Why?
| | Musculoskeletal Abnormalities | 1 | 1995 | 13 | 0.010 |
Why?
| | Xenopus | 1 | 1995 | 87 | 0.010 |
Why?
| | Palate | 1 | 1995 | 38 | 0.010 |
Why?
| | Musculoskeletal System | 1 | 1995 | 48 | 0.010 |
Why?
| | Estrus | 1 | 1994 | 11 | 0.010 |
Why?
| | Acetone | 1 | 1994 | 11 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 1998 | 718 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 1997 | 500 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1997 | 491 | 0.010 |
Why?
| | Skull | 1 | 1995 | 139 | 0.010 |
Why?
| | Dendritic Cells | 1 | 1997 | 483 | 0.010 |
Why?
| | Cell Fusion | 1 | 1993 | 51 | 0.010 |
Why?
| | Protein Kinase C | 1 | 1994 | 261 | 0.010 |
Why?
| | Organelles | 1 | 1991 | 58 | 0.010 |
Why?
| | Cell Line, Transformed | 1 | 1991 | 145 | 0.010 |
Why?
| | Retroviridae | 1 | 1991 | 97 | 0.010 |
Why?
| | Peptide Mapping | 1 | 1990 | 64 | 0.010 |
Why?
| | Trypsin | 1 | 1990 | 77 | 0.010 |
Why?
| | von Willebrand Factor | 1 | 1990 | 80 | 0.000 |
Why?
| | DNA, Recombinant | 2 | 1979 | 47 | 0.000 |
Why?
| | RNA Probes | 1 | 1988 | 13 | 0.000 |
Why?
| | Autoradiography | 1 | 1988 | 78 | 0.000 |
Why?
| | HLA-DR Antigens | 1 | 1990 | 228 | 0.000 |
Why?
| | Histocytochemistry | 1 | 1988 | 80 | 0.000 |
Why?
| | Metaphase | 1 | 1988 | 31 | 0.000 |
Why?
| | Microbial Collagenase | 1 | 1987 | 12 | 0.000 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 1988 | 49 | 0.000 |
Why?
| | Cytoplasm | 1 | 1988 | 274 | 0.000 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 1988 | 114 | 0.000 |
Why?
| | Culture Techniques | 1 | 1987 | 81 | 0.000 |
Why?
| | Light | 1 | 1990 | 381 | 0.000 |
Why?
| | Cross Reactions | 1 | 1988 | 133 | 0.000 |
Why?
| | Leukemia, Radiation-Induced | 1 | 1987 | 4 | 0.000 |
Why?
| | Proto-Oncogene Proteins c-sis | 1 | 1987 | 39 | 0.000 |
Why?
| | Leukemia, Experimental | 1 | 1987 | 27 | 0.000 |
Why?
| | Cricetulus | 1 | 1987 | 109 | 0.000 |
Why?
| | Diterpenes | 1 | 1986 | 31 | 0.000 |
Why?
| | Genetic Markers | 1 | 1987 | 344 | 0.000 |
Why?
| | Inflammation | 1 | 1997 | 2837 | 0.000 |
Why?
| | Incidence | 1 | 1991 | 2804 | 0.000 |
Why?
| | Lipopolysaccharides | 1 | 1988 | 886 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1996 | 7635 | 0.000 |
Why?
| | Poly A | 1 | 1982 | 51 | 0.000 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 1979 | 57 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1991 | 15657 | 0.000 |
Why?
|
|
Roop's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|